Skip to main content
Home
❮ Back to EMA website

Main navigation

  • Annual Report Homepage
  • Foreword
  • Introduction
  • COVID-19: The European medicines regulatory network’s response to the pandemic
  • CHAPTER 1
  • Key achievements in 2021
  • Evaluation and monitoring of medicines: highlights
  • Regulation of veterinary medicines
  • Fighting antimicrobial resistance
  • Clinical trials in the EU – improving the clinical research environment
  • Data Analytics and Methods
  • Information Management and Digital Business Transformation
  • Protecting IT systems against cyberattacks
  • Regulatory Science and Innovation
  • Strengthening EMA’s role in crisis preparedness and management of public health threats
  • Medical devices legislation
  • International regulatory cooperation to improve global health
  • 2021 - year in brief
  • CHAPTER 2
  • Data Highlights
  • Human medicines
  • Veterinary medicines
  • Inspections and compliance
  • Network, stakeholders, administration and communication

2021 - year in brief

Share:
Previous
International regulatory cooperation to improve global health
Next
Chapter 2: Human medicines
  • Past annual reports
  • Ask a question
  • Help us with your feedback
  • Back to EMA corporate website
  • RSS
  • Twitter
  • YouTube
  • LinkedIn
© 2022 European Medicines Agency